Test of circulating tumor cells offers less invasive option for multiple myeloma surveillance, staging, and biological study compared to bone marrow biopsies
Bill Sellers, head of Ó³»´«Ã½â€™s Cancer Program, talks about how to discover new classes of genetic dependencies that could move therapies closer to curing cancer patients.